Is IDEXX Laboratories Inc. (IDXX) the Best Quality Stock to Buy According to Analysts?
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $500
Express News | IDEXX Laboratories Inc : Stifel Cuts Target Price to $500 From $510
Are Options Traders Betting on a Big Move in IDEXX Laboratories (IDXX) Stock?
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching
IDEXX Laboratories to Release 2024 Third Quarter Financial Results
IDEXX Laboratories (NASDAQ:IDXX) Ticks All The Boxes When It Comes To Earnings Growth
IDEXX Laboratories' (NASDAQ:IDXX) Five-year Earnings Growth Trails the Favorable Shareholder Returns
Could The Market Be Wrong About IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Its Attractive Financial Prospects?
Those Who Invested in IDEXX Laboratories (NASDAQ:IDXX) Five Years Ago Are up 78%
A Look At The Fair Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
$100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth This Much Today
$100 Invested In This Stock 10 Years Ago Would Be Worth $800 Today
BofA Securities Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $550
BofA Securities analyst Michael Ryskin maintains $IDEXX Laboratories Inc(IDXX.US)$ with a hold rating, and maintains the target price at $550.According to TipRanks data, the analyst has a success
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $589
Morgan Stanley analyst Erin Wright maintains $IDEXX Laboratories Inc(IDXX.US)$ with a buy rating, and maintains the target price at $589.According to TipRanks data, the analyst has a success rate of 6
BTIG Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $580
BTIG analyst Mark Massaro maintains $IDEXX Laboratories Inc(IDXX.US)$ with a buy rating, and maintains the target price at $580.According to TipRanks data, the analyst has a success rate of 31.2%
Piper Sandler Maintains Neutral on IDEXX Laboratories, Lowers Price Target to $520
IDEXX Laboratories Analyst Ratings
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $607 From $641